HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)

SHA:600829 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 2, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,547	4,349	4,535	3,700	3,897	4,303
Market Cap Growth	43.82%	-4.09%	22.57%	-5.06%	-9.43%	8.80%
Enterprise Value	6,660	4,499	4,654	3,912	4,575	4,515
Last Close Price	11.29	7.50	7.62	6.22	6.55	7.09
PE Ratio	54.95	20.39	15.52	13.99	14.05	29.62
PS Ratio	0.64	0.43	0.44	0.38	0.42	0.54
PB Ratio	2.19	1.51	1.65	1.51	1.77	2.16
P/TBV Ratio	2.21	1.52	1.66	1.52	1.80	2.19
P/FCF Ratio	203.64	40.50	14.65	12.30	-	-
P/OCF Ratio	146.16	37.68	13.62	12.04	-	-
EV/Sales Ratio	0.65	0.45	0.45	0.41	0.49	0.56
EV/EBITDA Ratio	25.96	14.10	10.78	9.69	10.48	16.26
EV/EBIT Ratio	33.82	15.00	11.31	10.21	11.08	17.86
EV/FCF Ratio	207.17	41.89	15.04	13.00	-	-
Debt / Equity Ratio	0.25	0.31	0.37	0.52	0.60	0.31
Debt / EBITDA Ratio	2.86	2.50	2.16	2.84	2.80	2.20
Debt / FCF Ratio	22.83	8.38	3.29	4.22	-	-
Asset Turnover	1.45	1.38	1.44	1.40	1.46	1.39
Inventory Turnover	8.63	8.29	8.59	8.02	7.48	6.26
Quick Ratio	1.37	1.33	1.27	1.22	1.15	1.11
Current Ratio	1.68	1.62	1.53	1.48	1.42	1.43
Return on Equity (ROE)	4.06%	7.57%	11.22%	11.36%	13.19%	7.55%
Return on Assets (ROA)	1.75%	2.57%	3.55%	3.47%	4.05%	2.74%
Return on Invested Capital (ROIC)	4.63%	8.62%	12.23%	11.12%	12.97%	7.96%
Return on Capital Employed (ROCE)	6.30%	9.90%	14.20%	14.60%	17.30%	11.90%
Earnings Yield	1.82%	4.90%	6.44%	7.15%	7.12%	3.38%
FCF Yield	0.49%	2.47%	6.83%	8.13%	-6.29%	-0.54%
Dividend Yield	-	-	1.89%	-	-	1.69%
Payout Ratio	21.47%	75.22%	8.43%	11.53%	12.86%	2.93%
Buyback Yield / Dilution	0.02%	0.01%	-0.01%	0.00%	0.20%	-0.20%
Total Shareholder Return	0.02%	0.01%	1.88%	0.00%	0.20%	1.49%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.